Andrew L. Busser
Chief Executive Officer at The Pitcairn Trust Co.
Network origin in Andrew L. Busser first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Subsidiary | Pharmaceuticals: Major | 9 | |
The Pitcairn Trust Co.
 The Pitcairn Trust Co. Investment ManagersFinance The Pitcairn Trust Co. is one of the preeminent multi-family offices, dedicated to helping families protect and grow their substantial financial assets and unique heritage across multiple generations. Pitcairn has been recognized as an innovator and leader in the multi-family office space since its inception in 1923. It delivers objective advice and customized services.
9
| Subsidiary | Investment Managers | 9 |
Symphony Capital LLC
 Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York.
6
| Private Company | Investment Managers | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew L. Busser via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| INCYTE CORPORATION | Pharmaceuticals: Major | President Chief Executive Officer Director of Finance/CFO | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Caliper Life Sciences, Inc.
 Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Semiconductors | President | |
| AGENUS INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology AvidBiotics Corp. operates as a biotechnology company. It develops therapeutic proteins designed to destroy target cells with laser precision, including cancer cells, virus-infected cells, and pathogenic bacteria. The company was founded by David W. Martin, James L. Knighton, and Jeffrey F. Miller in 2005 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder | |
| University of Notre Dame | College/University | Undergraduate Degree | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Director/Board Member Graduate Degree Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Research - Equity General Counsel | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Symphony Genisis, Inc.
 Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Symphony Dynamo, Inc.
 Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Biotechnology | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Symphony Icon, Inc.
 Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Founder | |
American Society for Biochemistry & Molecular Biology, Inc.
 American Society for Biochemistry & Molecular Biology, Inc. Miscellaneous Commercial ServicesCommercial Services The American Society for Biochemistry and Molecular Biology, Inc. is an international non-profit scientific and educational organization based in Bethesda, MD. With over 11,000 members, the society is one of the largest molecular life science societies in the world. The society serves the scientific community through the publication of peer-reviewed journals and science news, organization of scientific meetings, advocacy for funding of basic research and education, support of career development and science education at all levels, promoting the diversity of individuals entering the scientific workforce, and celebrating important contributions and achievements in science and technology made by black scientists. The society also honors an outstanding scientist who has shown a sustained commitment to breaking down local and/or systemic barriers against scientists and students from historically marginalized or excluded groups. Founded in 1906, the society's mission is to advance the science of biochemistry and molecular biology and promote the understanding of the molecular nature of life processes. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | ||
| DuPont Pharmaceuticals Research Laboratories | President | ||
Symphony ViDA, Inc.
 Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Wilkerson Partners LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Chairman Corporate Officer/Principal | |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | Biotechnology | Founder Founder | |
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Xyphos Biosciences, Inc. engages in biotechnology business. The firm’s novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform allows new ways to mobilize and control immune cells to find and destroy specifically targeted cells throughout the body. The company was founded by David W. Martin, Jr. and James L. Knighton and is headquartered in South San Francisco, CA. | Biotechnology | Founder Founder | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder | |
Isosceles Pharmaceuticals, Inc.
 Isosceles Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Isosceles Pharmaceuticals, Inc. is a preclinical stage biotechnology and medical device company that focuses on delivering drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The private company is based in Wilmington, NC. The company's proprietary formulations, coupled with unique delivery platforms, provide high bioavailability via parenteral and transdermal routes. Isosceles Pharmaceuticals is a specialty pharmaceutical company with a pipeline of parenteral products designed to target the unmet need of novel non-opioid, non-NSAID analgesics to treat acute pain. William D. Humphries has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 51 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 168 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 54 |
| Chairman | 36 |
| Founder | 30 |
Most connected contacts
| Insiders | |
|---|---|
| Osagie Imasogie | 37 |
| Robert Stein | 34 |
| Alan Frazier | 31 |
| Samuel D. Colella | 31 |
| Wayne Walker | 30 |
| J. Buchi | 26 |
| Joseph Turner | 22 |
| Paul Friedman | 21 |
| Mark Kessel | 18 |
| Hal Barron | 16 |
| David W. Martin | 16 |
| Joseph A. Mollica | 14 |
| James L. Knighton | 11 |
| Alastair J. J. Wood | 11 |
| John A. Barrett | 10 |
- Stock Market
- Insiders
- Andrew L. Busser
- Company connections
